A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area

Hussein, Jemal; Zewdie, Martha; Yamuah, Lawrence; Bedru, Ahmed; Abebe, Markos; Dagnew, Alemnew F.; Chanyalew, Menberework; Yohannes, Asfawesen G.; Ahmed, Jemal; Engers, Howard; Doherty, T. Mark; Bang, Peter; Kromann, Ingrid; Hoff, Søren T.; Aseffa, Abraham

doi:10.1186/s13063-017-2354-0

Trials

Article metrics
Last updated: Tue, 16 Apr 2024 4:30:06 Z

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area

Access & Citations

2197

Article Accesses
16

Web of Science
19

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com